Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis. - De Paz Linares, Guillermo Antonio; Opperman, Reid Morgan; Majumder, Mousumi; Lala, Peeyush K.; Hodivala-Dilke, Kairbaan; Munoz-Felix, Jose M. (Cancers, 2021)